Theravance Biopharma, Inc.
TBPH
Revenue
15.39M
▼-3.37M▼-17.95%
3 Months ChangeAssets
343.58M
▼-10.58M▼-2.99%
3 Months ChangeLiabilities
177.60M
▼-1.02M▼-0.5694%
3 Months ChangeFree Cash Flow
-1.11M
▲11.05M▲90.85%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-23
Form 8-K
ID: 0001104659-24-101816
2024-09-10
Form 8-K
ID: 0001104659-24-098326
2024-08-08
Form 10-Q
ID: 0001558370-24-011636
2024-08-05
Form 8-K
ID: 0001104659-24-085826
2024-05-15
Form 10-Q
ID: 0001558370-24-008201
2024-05-13
Form 8-K
ID: 0001104659-24-060536
2024-05-09
Form 8-K
ID: 0001104659-24-059338
2024-02-28
Form 8-K
ID: 0001104659-24-028809
2024-02-26
Form 8-K
ID: 0001104659-24-027510
2024-01-16
Form 8-K
ID: 0001104659-24-003852